Draft Guidance for Industry on Tobacco Health Document Submission; Availability, 68629 [E9-30657]
Download as PDF
Federal Register / Vol. 74, No. 247 / Monday, December 28, 2009 / Notices
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by
email to
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Dated: December 18, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E9–30606 Filed 12–24–09; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–D–0600]
Draft Guidance for Industry on
Tobacco Health Document
Submission; Availability
AGENCY:
Food and Drug Administration,
HHS.
erowe on DSK5CLS3C1PROD with NOTICES
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a draft guidance
document entitled ‘‘Tobacco Health
Document Submission.’’ The draft
guidance is intended to assist persons
making certain document submissions
to FDA under the Family Smoking
Prevention and Tobacco Control Act
(Tobacco Control Act).
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
written or electronic comments on the
draft guidance by January 22, 2010.
ADDRESSES: Submit written requests for
single copies of the draft guidance
document entitled ‘‘Tobacco Health
Document Submission’’ to the Center for
Tobacco Products, Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850–3229. Send one
self-addressed adhesive label to assist
that office in processing your request or
include a fax number to which the draft
guidance document may be sent.
Submit electronic comments to https://
www.regulations.gov. Submit written
comments on the guidance to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852. Identify comments with the
VerDate Nov<24>2008
11:00 Dec 24, 2009
Jkt 220001
docket number found in brackets in the
heading of this document. See the
SUPPLEMENTARY INFORMATION section for
electronic access to the guidance
document.
FOR FURTHER INFORMATION CONTACT: May
Nelson, Center for Tobacco Products,
Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850–
3229, 240–276–1717,
May.Nelson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
On June 22, 2009, the President
signed the Tobacco Control Act (Public
Law 111–31) into law. The Tobacco
Control Act amended the Federal Food,
Drug, and Cosmetic Act (the act) (21
U.S.C. 301 et seq.) by, among other
things, adding a new chapter granting
FDA important new authority to
regulate the manufacture, marketing,
and distribution of tobacco products to
protect the public health generally and
to reduce tobacco use by minors.
Section 904(a)(4) of the act, as
amended by the Tobacco Control Act,
requires each tobacco product
manufacturer or importer, or agent
thereof, to submit all documents
developed after June 22, 2009, ‘‘* * *
that relate to health, toxicological,
behavioral, or physiologic effects of
current or future tobacco products, their
constituents (including smoke
constituents), ingredients, components,
and additives.’’ Information required
under section 904(a)(4) of the act must
be submitted to FDA beginning
December 22, 2009. FDA recognizes the
challenges associated with the
collection, review, organization, and
production of documents. We also
recognize that additional time may be
necessary for the production of
documents in a digital format, which
FDA strongly encourages in order to
improve the management and
accessibility of submitted documents.
Therefore, FDA does not intend to
enforce the December 22, 2009, deadline
provided you submit by April 30, 2009,
all documents described in section
904(a)(4) of the act developed between
June 23, 2009, and March 31, 2010.
II. Significance of Guidance
FDA is issuing this draft guidance
document consistent with FDA’s good
guidance practices regulation (21 CFR
10.115). The draft guidance, when
finalized, will represent the agency’s
current thinking on ‘‘Tobacco Health
Document Submission.’’ It does not
create or confer any rights for or on any
person and does not operate to bind
FDA or the public. An alternative
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
68629
approach may be used if such approach
satisfies the requirements of the
applicable statute and regulations.
III. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. The draft
guidance document and received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
IV. Paperwork Reduction Act of 1995
This draft guidance contains proposed
collections of information that are
subject to review by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501–3520). As
required by the PRA, FDA has
published an analysis of, among other
information collections, the information
collection concerning the submission of
tobacco health documents (74 FR 45219,
September 1, 2009, as corrected by 74
FR 47257, September 15, 2009) and will
submit them for OMB approval.
V. Electronic Access
An electronic version of the guidance
document is available on the Internet at
https://www.regulations.gov and https://
www.fda.gov/TobaccoProducts/
GuidanceComplianceRegulatory
Information/default.htm.
Dated: December 22, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–30657 Filed 12–22–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\28DEN1.SGM
28DEN1
Agencies
[Federal Register Volume 74, Number 247 (Monday, December 28, 2009)]
[Notices]
[Page 68629]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30657]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-D-0600]
Draft Guidance for Industry on Tobacco Health Document
Submission; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance document entitled ``Tobacco Health
Document Submission.'' The draft guidance is intended to assist persons
making certain document submissions to FDA under the Family Smoking
Prevention and Tobacco Control Act (Tobacco Control Act).
DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the agency considers your comment on this
draft guidance before it begins work on the final version of the
guidance, submit written or electronic comments on the draft guidance
by January 22, 2010.
ADDRESSES: Submit written requests for single copies of the draft
guidance document entitled ``Tobacco Health Document Submission'' to
the Center for Tobacco Products, Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850-3229. Send one self-addressed
adhesive label to assist that office in processing your request or
include a fax number to which the draft guidance document may be sent.
Submit electronic comments to https://www.regulations.gov. Submit
written comments on the guidance to the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. Identify comments with the docket number found in
brackets in the heading of this document. See the SUPPLEMENTARY
INFORMATION section for electronic access to the guidance document.
FOR FURTHER INFORMATION CONTACT: May Nelson, Center for Tobacco
Products, Food and Drug Administration, 9200 Corporate Blvd.,
Rockville, MD 20850-3229, 240-276-1717, May.Nelson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
On June 22, 2009, the President signed the Tobacco Control Act
(Public Law 111-31) into law. The Tobacco Control Act amended the
Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 301 et seq.)
by, among other things, adding a new chapter granting FDA important new
authority to regulate the manufacture, marketing, and distribution of
tobacco products to protect the public health generally and to reduce
tobacco use by minors.
Section 904(a)(4) of the act, as amended by the Tobacco Control
Act, requires each tobacco product manufacturer or importer, or agent
thereof, to submit all documents developed after June 22, 2009, ``* * *
that relate to health, toxicological, behavioral, or physiologic
effects of current or future tobacco products, their constituents
(including smoke constituents), ingredients, components, and
additives.'' Information required under section 904(a)(4) of the act
must be submitted to FDA beginning December 22, 2009. FDA recognizes
the challenges associated with the collection, review, organization,
and production of documents. We also recognize that additional time may
be necessary for the production of documents in a digital format, which
FDA strongly encourages in order to improve the management and
accessibility of submitted documents. Therefore, FDA does not intend to
enforce the December 22, 2009, deadline provided you submit by April
30, 2009, all documents described in section 904(a)(4) of the act
developed between June 23, 2009, and March 31, 2010.
II. Significance of Guidance
FDA is issuing this draft guidance document consistent with FDA's
good guidance practices regulation (21 CFR 10.115). The draft guidance,
when finalized, will represent the agency's current thinking on
``Tobacco Health Document Submission.'' It does not create or confer
any rights for or on any person and does not operate to bind FDA or the
public. An alternative approach may be used if such approach satisfies
the requirements of the applicable statute and regulations.
III. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) written or electronic comments regarding this document.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. The draft guidance document and
received comments may be seen in the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday through Friday.
IV. Paperwork Reduction Act of 1995
This draft guidance contains proposed collections of information
that are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520).
As required by the PRA, FDA has published an analysis of, among other
information collections, the information collection concerning the
submission of tobacco health documents (74 FR 45219, September 1, 2009,
as corrected by 74 FR 47257, September 15, 2009) and will submit them
for OMB approval.
V. Electronic Access
An electronic version of the guidance document is available on the
Internet at https://www.regulations.gov and https://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/default.htm.
Dated: December 22, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-30657 Filed 12-22-09; 8:45 am]
BILLING CODE 4160-01-S